Clinical Trials Arena on MSN

Genespire to take rare disease gene therapy to clinic in 2026

GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Adopted ‘Aussie’ Katie Boulter goes down swinging in Australian Open defeat

Belinda Bencic continued her strong form from the United Cup but Boulter put up a fight after a one-sided opening set ...